- Supported exchanges /
- NSE /
- INDSWFTLTD.NSE
Ind-Swift Limited (INDSWFTLTD NSE) stock market data APIs
Ind-Swift Limited develops pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. The company offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names. It also offers medicines for various therapeutic comprising gynaecology, pediatrics, dermatology, and other generic medicines under the Anin, Suprox, Cozy, Distone, and Oliade name. In addition, the company provides antibiotic, anti-cold, nutraceuticals, anti-diarrhoeal, anti-malarial, anti-depressants, cardiology, diabetology, anti-depressant, anti-allergic, anti- infective, neurology, and oncology. Ind-Swift Limited provides Ayurvedic products, as well as contract research and manufacturing services. The company exports its products, as well as licenses its products to Europe, Australia, Canada, South Africa, and Russia. Swift Limited was founded in 1983 and is based in Chandigarh, India.
Ind-Swift Limited Financial Data Overview
20.22 | |
21 | |
- | |
21 | |
20.17 | |
14.3-31.2 | |
1 095 M | |
1.9941 | |
54 165 K | |
4 676 M | |
-0.109 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Ind-Swift Limited Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 676 M
- EBITDA 398 M
- Earnings Per Share 10.14
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Ind-Swift Limited Earnings via APIs
- Latest Release 2024-11-07
- EPS/Forecast NaN
Get Ind-Swift Limited End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: